SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-19-004020
Filing Date
2019-07-11
Accepted
2019-07-11 10:28:06
Documents
6
Period of Report
2019-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bkit_8k.htm 8-K 14810
2 FORM OF ASSIGNMENT AGREEMENT bkit_ex101.htm EX-10.1 1906
3 PRESS RELEASE bkit_ex991.htm EX-99.1 6035
4 bkit_ex101img1.jpg GRAPHIC 488514
5 bkit_ex101img2.jpg GRAPHIC 569509
6 bkit_ex101img3.jpg GRAPHIC 144441
  Complete submission text file 0001477932-19-004020.txt   1680546
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 (646) 453-4912
BIOHEMP INTERNATIONAL, INC. (Filer) CIK: 0001556416 (see all company filings)

IRS No.: 460780380 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-55022 | Film No.: 19950519
SIC: 7200 Services-Personal Services